1536 Journal of Natural Products, 2008, Vol. 71, No. 9
Clark et al.
It should be noted that for many of the tumonoic acids, a second,
minor set of NMR signals was observed (<10% height of major peaks
in all cases). These were attributed to minor isomers caused by
cis-trans proline isomerization.
A small subsample of each of the synthetic tumonoic acids was
hydrolyzed at 110 °C in dioxane-6 M HCl (1:1) for 18 h. The
hydrolysate was extracted with EtOAc, the organic layer reduced under
vacuum, and the residue purified by HPLC using a Phenomenex
Synergi-Hydro (4 µm, 21 × 250 mm) column, eluting with a gradient
from 50% CH3CN-H2O to 100% CH3CN at a flow rate of 4 mL/min.
The optical rotations of the purified methyldecanoic acids were
measured and compared with literature values.15 Compound 1 yielded
(2S)-2-methyldecanoic acid ([R]D +12.3 (CHCl3, c 0.26); lit. +5.1),
while the unnatural epimer 8 gave (2R)-2-methyldecanoic acid
([R]D -9.8 (CHCl3, c 0.32); lit. -5.1).
Absolute Configuration of the Proline Residues of Tumonoic
Acids D-I. The tumonoic acids (∼0.1 mg each) were hydrolyzed in
6 N HCl at 110 °C for 18 h and then extracted twice with EtOAc. The
aqueous layers were dried under a stream of N2 before derivatization
with 1-fluoro-2,4-dinitrophenyl-5-L-valerylamide (FDVA) in acetone
(50 µL) and 0.1 M NaHCO3 (100 µL) in sealed vials at 90 °C for 5
min. The resulting solutions were analyzed using RP HPLC using an
HP LiChrospher 100 RP-18 (5 µm, 4 × 125 mm) column, eluting with
50% CH3CN-H2O at a flow rate of 0.8 mL/min. The L-proline
derivative eluted at 7.7 min, with the D-proline derivative eluting at
8.9 min.
Chiral HPLC Analysis. Isoleucic acids were synthesized according
to literature methods.23 The organic layers from the acid hydrolysates
of 4, 5, and 6 were evaporated to dryness and then redissolved in 2
mM CuSO4. Analysis was carried out using three separate conditions.
Condition 1: 100% 2 mM CuSO4, 0.8 mL/min, Phenomenex Chirex
3126 (4.6 × 250 mm) column; elution times (tR, min) for standards:
L-lactic acid (22.1), D-lactic acid (29.2) min. Condition 2: 12.5% CH3CN
in 2 mM CuSO4, 0.8 mL/min, Phenomenex Chirex 3126 (4.6 × 250
mm) column; elution times (tR, min) for standards: L-2-hydroxyisova-
leric acid (7.8), D-2-hydroxyisovaleric acid (12.1) min. Condition 3:
12.5% CH3CN in 2 mM CuSO4, 0.8 mL/min, Phenomenex Chirex 3126
(4.6 × 50 mm) column; elution times (tR, min) for standards: L-allo-
isoleucic acid (18.3), L-isoleucic acid (21.4), D-allo-isoleucic acid (28.5),
D-isoleucic acid (34.1).
epi-Tumonoic acid D (8): colorless oil; [R]D -120 (c 0.67, CDCl3);
IR (neat) νmax 2958, 2930, 2857, 1736, 1642, 1601, 1468, 1450, 1333,
1
1191 cm-1; H NMR (CDCl3, 500 MHz) δH 9.26 (br s, COOH), 4.60
(d, J ) 4.7 Hz, H-2′), 3.63 (br t, J ) 8.6 Hz, H-5′a), 3.53 (ddd, J )
9.2, 8.7, 6.1 Hz, H-5′b), 2.57 (dq, J ) 6.8, 6.6 Hz, H-2), 2.41 (m,
H-3′a), 2.03 (m, H-3′b), 2.01 (m, H-4′, 1.67 (m, H-3a), 1.41 (m, H-3b),
1.28-1.25 (m, H-4 - H-9), 1.15 (d, J ) 6.6 Hz, 2-Me), 0.87 (t, J )
6.8 Hz, H-10); 13C NMR (CDCl3, 75 MHz) δC 179.1 (C-1), 172.8 (C-
1′), 59.9 (C-2′), 47.7 (C-5′), 38.1 (C-2), 33.5 (C-3), 31.8 (C-8), 29.6,
29.4, 29.2 (C-5-C-7), 27.5 (C-4), 27.4 (C-3′), 24.8 (C-4′), 22.6 (C-9),
17.2 (2-Me), 14.0 (C-10); ESI(+)MS m/z 284 [M + H]+
.
Biological Activity. All metabolites were tested for activity in
antimalarial,24 antileishmania,25 anti-Chagas,26 cytotoxicity (NCI-H460
lung tumor,27,28 L1210, colon 38, H-116, H-125M, CEM, and CFU-
GM cell lines29), antibacterial (MRSA),30 and quorum sensing assays.
Procedures for all assays except quorum sensing are given in the
appropriate references.
Quorum sensing assays were carried out using marine broth (MB)
containing 1 g of yeast extract and 5 g of peptone per liter of synthetic
seawater (Instant Ocean). For agar plates, 15 g of agar (USB) per liter
of H2O was used. 4-Bromo-5-(bromomethylene)-2-(5H)-furanone was
synthesized as reported previously.31 The 3-oxohexanoylhomoserine
lactone (OHHL) is commercially available (Sigma-Aldrich, lot #
102K3851).
Vibrio harVeyi BB120 produces bioluminescence in response to the
autoinducers HAI-1, AI-2, and CAI-1. V. harVeyi was cultured in MB
at 28 °C while shaking. An overnight culture of V. harVeyi BB120 in
MB was diluted to an OD600 of 0.1. An aliquot (100 µL) of the diluted
culture was added to 5 mL of MB. Test compounds dissolved in DMSO
were added to the wells of an opaque microtiter plate (Nunc A/S,
Denmark; 0.0076 to 250 µM final concentration; 0.5% DMSO
concentration; negative control ) DMSO alone). The synthesized
brominated furanone was utilized as a positive control for inhibition
of luminescence (0.0076 to 250 µM). The diluted V. harVeyi culture
was added to the wells and mixed thoroughly. The plates were incubated
for 4 h and read on a Packard Lumicount microtiter plate reader
(Packard, UK). Relative luminescence units were normalized by the
optical density (600 nm) values obtained by transferring 100 µL to a
clear-bottom microtiter plate.
Escherichia coli JB525 is E. coli MT102 harboring the gfp plasmid
pJBA132. This mutant produces an unstable green fluorescent protein
in response to a C6-C8 N-acyl-homoserine lactone autoinducer. E.
coli JB525 was cultured in LB4 broth at 30 °C. Inhibition of
fluorescence was determined using a method modified from Anderson
et al.16 An overnight culture of E. coli JB525 in LB4 broth was diluted
to an OD450 of 0.25 with fresh media. Test compounds dissolved in
DMSO, or DMSO alone, were added to the wells of an opaque
microtiter plate (Nunc A/S, Denmark; 32 nM OHHL; 0.0076 to 250
µM test compounds; 1% DMSO concentration). The diluted E. coli
culture was added to the wells and mixed thoroughly. The plates were
incubated with shaking at 30 °C for 90 min. Fluorescence was
determined using a Packard Fluorocount microtiter plate reader (λ )
480 nm excitation, λ ) 515 nm emission). Relative fluorescence values
were normalized by optical density values obtained by transferring 100
µL to a clear-bottom microtiter plate (λ ) 450 nm, SpectraMax
Multimode microplate reader, Molecular Devices).
The hydrolysates of 4, 5, and 6 were analyzed by the methods above,
revealing the presence of L-lactic acid and D-allo-isoleucic acid in 4;
L-2-hydroxyisovaleric acid and D-2-hydroxyisovaleric acid in 5; and
L-isoleucic acid and D-allo-isoleucic acid in 6.
To define the positions of the hydroxy acids in 5 and 6, both were
separately derivatized using L-(-)-R-methylbenzylamine using the
following method: 0.2 mg of the natural product was dissolved in 100
µL of CH2Cl2, the solution was cooled to 0 °C, and solutions of L-(-)-
R-methylbenzylamine (12 µL), triethylamine (12 µL), EDAC ·HCl (18
µL), and DMAP (12 µL) (all solutions 5 mg/mL) were added
sequentially. The mixture was allowed to stir overnight, with LCMS
analysis indicating complete conversion to the desired products. The
crude products were evaporated to dryness, resuspended in CH2Cl2,
and washed sequentially with 0.1 M HCl, H2O, 1 M NaHCO3, H2O,
and brine. The organic layers were evaporated to dryness and the
residues resuspended in MeOH-1 M NaOH (1:1) and left to stir
overnight at room temperature. The MeOH was removed under N2,
and the aqueous residue acidified with 2 M HCl and then extracted
twice with EtOAc. The EtOAc was removed under N2, and the samples
were suspended in 2 mM CuSO4 and analyzed by the relevant chiral
HPLC methods as described above, revealing the presence of free D-2-
hydroxyisovaleric acid in 5 and D-allo-isoleucic acid in 6.
Synthesis of Tumonoic Acid D Epimers. Commercially available
racemic 2-methyldecanoic acid (50 mg) was dissolved in 2 mL of
CH2Cl2, the mixture was cooled to 0 °C, and L-proline methyl ester
(30 mg), triethylamine (30 mg), EDAC·HCl (51 mg), and DMAP (33
mg) were added sequentially. The mixture was allowed warm to room
temperature over 30 min and then stirred for 18 h, with LCMS analysis
indicating complete conversion to the desired products. The crude
products were evaporated to dryness and resuspended in EtOAc, the
slurry was filtered, and then the organic solubles were washed as above
to yield the crude product (52 mg). The mixture was then hydrolyzed
in EtOH-1 M NaOH (1:1) overnight at room temperature. The aqueous
layer was acidified with 1 M HCl and extracted twice with EtOAc,
and the organic layer was evaporated to dryness to yield the epimeric
acids 1 and 8 (40 mg).
The two epimeric products were separated by RP HPLC using a
Phenomenex Jupiter (10 µm, 21 × 250 mm) column, eluting with 45%
CH3CN-H2O at a flow rate of 4 mL/min to give tumonoic acid D (1,
14.2 mg) and the unnatural epimer 8 (13.8 mg). Co-injections with
natural 1 were used to confirm which was the natural isomer, using
the following HPLC conditions: HP LiChrospher 100 RP-18 (5 µm, 4
× 125 mm) column, eluting with 40% CH3CN-H2O at a flow rate of
0.8 mL/min. Elution times (tR, min): 1 (27.5), 8 (31.7).
Acknowledgment. We gratefully acknowledge the government of
Papua New Guinea for permission to make these collections, and T. L.
Simmons, R. Grindberg, and C. Sorrels for collection of the organisms.
We also thank S. Kelly, J. Wingerd, D. Kyle, and L. D. Urena for
conducting biological assays, and A. Pereira for recording the optical
rotation of tumonoic acid A. Financial support for this work came from